Arrayit Corp ARYC
Morningstar’s Analysis
1-Star Price
PREMIUM
5-Star Price
PREMIUM
Economic Moat
PREMIUM
There is no one analyst in which a Quantitative Star Rating and Fair Value Estimate is attributed to; however, Mr. Lee Davidson, Head of Quantitative Research for Morningstar, Inc., is responsible for overseeing the methodology that supports the quantitative fair value. As an employee of Morningstar, Inc., Mr. Davidson is guided by Morningstar, Inc.'s Code of Ethics and Personal Securities Trading Policy in carrying out his responsibilities. For information regarding Conflicts of Interests, click here .
Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.
Company Profile
Arrayit Corp is a developer, manufacturer, and marketer of next-generation life science tools and integrated systems for the large-scale analysis of genetic variation, biological function, and diagnostics. Using its proprietary and patented technologies, it provides a comprehensive line of products and services that currently serve the sequencing, genotyping, and protein analysis markets. In addition, it also provides tools and services to genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations, government agencies and biotechnology companies. Its products include microarrayers, buffers, microarray instruments, printing, substrate slides, software and others. The operations of the firm are carried out through the region of US.
Sunnyvale, CA, 94085